Piramal Pharma reports consolidated net loss of Rs 136.19 crore in the December 2025 quarter
(29 Jan 2026)

Back
Net loss of Piramal Pharma reported to Rs 136.19 crore in the quarter ended December 2025 as against net profit of Rs 3.68 crore during the previous quarter ended December 2024. Sales declined 2.92% to Rs 2139.87 crore in the quarter ended December 2025 as against Rs 2204.22 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales2139.872204.22 -3
OPM %9.1515.32 -
PBDT159.99263.61 -39
PBT-52.7566.80 PL
NP-136.193.68 PL

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew